Krishna, Neel K.
Contact Info
Publications
selected publications
-
2019Peptide Inhibitor of Complement C1 (PIC1) Inhibits Growth of Pathogenic Bacteria. INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS. 25:83-92.Full Text via DOI: 10.1007/s10989-017-9651-z
-
2019Inhibition of complement activation, myeloperoxidase, NET formation and oxidant activity by PIC1 peptide variants.. PLOS ONE. 14.Full Text via DOI: 10.1371/journal.pone.0226875 PMID: 31891617
-
2018Peptide inhibitor of complement C1 modulates transfusion related acute lung injury in a novel rat model. MOLECULAR IMMUNOLOGY. 177-177.Full Text via DOI: 10.1016/j.molimm.2018.06.129
-
2018Inhibition of Immune Complex Complement Activation and Neutrophil Extracellular Trap Formation by Peptide Inhibitor of Complement C1. FRONTIERS IN IMMUNOLOGY. 9.Full Text via DOI: 10.3389/fimmu.2018.00558 PMID: 29632531
-
2018Peptide Inhibitor of Complement C1 (PIC1) demonstrates antioxidant activity via single electron transport (SET) and hydrogen atom transfer (HAT). PLOS ONE. 13.Full Text via DOI: 10.1371/journal.pone.0193931 PMID: 29499069
-
2017Therapeutic hypothermia modulates complement factor C3a and C5a levels in a rat model of hypoxic ischemic encephalopathy. PEDIATRIC RESEARCH. 81:654-662.Full Text via DOI: 10.1038/pr.2016.271 PMID: 28002390
-
2017Complement effectors, C5a and C3a, in cystic fibrosis lung fluid correlate with disease severity. PLOS ONE. 12.Full Text via DOI: 10.1371/journal.pone.0173257 PMID: 28278205
-
2017Discriminating the hemolytic risk of blood type A plasmas using the complement hemolysis using human erythrocytes (CHUHE) assay. TRANSFUSION. 57:517-524.Full Text via DOI: 10.1111/trf.13948 PMID: 28000304
-
2017Inhibition of Myeloperoxidase Activity in Cystic Fibrosis Sputum by Peptide Inhibitor of Complement C1 (PIC1). PLOS ONE. 12.Full Text via DOI: 10.1371/journal.pone.0170203 PMID: 28135312
-
2017Complement Activation and STAT4 Expression Are Associated with Early Inflammation in Diabetic Wounds. PLOS ONE. 12.Full Text via DOI: 10.1371/journal.pone.0170500 PMID: 28107529
-
2017Peptide Inhibitor of Complement C1 Inhibits the Peroxidase Activity of Hemoglobin and Myoglobin.. International journal of peptides. 9454583.Full Text via DOI: 10.1155/2017/9454583 PMID: 29081812
-
2016Peptide inhibitor of complement C1 modulates acute intravascular hemolysis of mismatched red blood cells in rats. TRANSFUSION. 56:2133-2145.Full Text via DOI: 10.1111/trf.13674 PMID: 27282513
-
2016Discriminating complement-mediated acute transfusion reaction for type O plus red blood cells transfused into a B plus recipient with the complement hemolysis using human erythrocytes (CHUHE) assay. TRANSFUSION. 56:1845-1848.Full Text via DOI: 10.1111/trf.13592 PMID: 26997226
-
2016Eosinophil Quantitated Urine Kinetic A novel assay for assessment of eosinophilic esophagitis. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY. 116:435-439.Full Text via DOI: 10.1016/j.anai.2016.02.011 PMID: 27017558
-
2015Complement Effectors of Inflammation in Cystic Fibrosis Lung Fluid Correlate with Clinical Measures of Disease. PLOS ONE. 10.Full Text via DOI: 10.1371/journal.pone.0144723 PMID: 26642048
-
2015Peptide Inhibitor of Complement significantly reduces brain injury in a rat model of neonatal hypoxic ischemic encephalopathy. MOLECULAR IMMUNOLOGY. 181-182.
-
2015Therapeutic hypothermia modulates C3a and C5a levels in a rat model of neonatal hypoxic ischemic encephalopathy. MOLECULAR IMMUNOLOGY. 181-181.
-
2015Peptide Inhibitor of Complement C1 (PIC1) Rapidly Inhibits Complement Activation after Intravascular Injection in Rats. PLOS ONE. 10.Full Text via DOI: 10.1371/journal.pone.0132446 PMID: 26196285
-
2014Complement inhibition significantly decreases red blood cell lysis in a rat model of acute intravascular hemolysis. TRANSFUSION. 54:2892-2900.Full Text via DOI: 10.1111/trf.12695 PMID: 24806146
-
2014Hyperglycemia inhibits complement-mediated immunological control of S. aureus in a rat model of peritonitis. MOLECULAR IMMUNOLOGY. 263-264.
-
2014Development of a Novel Assay for Measuring Complement-induced Hemolysis. TRANSFUSION. 171A-171A.
-
2014PeptiDe inhibitor of complement C1, a novel suppressor of classical pathway activation: mechanistic studies and clinical potential. FRONTIERS IN IMMUNOLOGY.Full Text via DOI: 10.3389/fimmu.2014.00406 PMID: 25202312
-
2014Clinical hypothermia temperatures increase complement activation and cell destruction via the classical pathway. JOURNAL OF TRANSLATIONAL MEDICINE. 12.Full Text via DOI: 10.1186/1479-5876-12-181 PMID: 24962100
-
2014C1q binding to dengue virus decreases levels of infection and inflammatory molecules transcription in THP-1 cells. VIRUS RESEARCH. 179:231-234.Full Text via DOI: 10.1016/j.virusres.2013.11.007 PMID: 24246304
-
2014Hyperglycemia Inhibits Complement-Mediated Immunological Control of S-aureus in a Rat Model of Peritonitis. JOURNAL OF DIABETES RESEARCH.Full Text via DOI: 10.1155/2014/762051 PMID: 25610878
-
2013Evolutionary dynamics of bovine coronaviruses: natural selection pattern of the spike gene implies adaptive evolution of the strains. JOURNAL OF GENERAL VIROLOGY. 94:2036-2049.Full Text via DOI: 10.1099/vir.0.054940-0 PMID: 23804565
-
2013A novel peptide inhibitor of classical and lectin complement activation including ABO incompatibility. MOLECULAR IMMUNOLOGY. 53:132-139.Full Text via DOI: 10.1016/j.molimm.2012.07.012 PMID: 22906481
-
2013Complement regulator C4BP binds to Staphylococcus aureus surface proteins SdrE and Bbp inhibiting bacterial opsonization and killing.. Results in immunology. 114-21.Full Text via DOI: 10.1016/j.rinim.2013.10.004 PMID: 24600566
-
2012Inhibition of ABO incompatibility using a novel small peptide. IMMUNOBIOLOGY. 1178-1179.Full Text via DOI: 10.1016/j.imbio.2012.08.143
-
2012Role of Molecular Diagnostics in the Management of Infectious Disease Emergencies. MEDICAL CLINICS OF NORTH AMERICA. 96:1067-+.Full Text via DOI: 10.1016/j.mcna.2012.08.005 PMID: 23102477
-
2012Hyperglycemic conditions inhibit C3-mediated immunologic control of Staphylococcus aureus. JOURNAL OF TRANSLATIONAL MEDICINE. 10.Full Text via DOI: 10.1186/1479-5876-10-35 PMID: 22390383
-
2010Potent inhibition of the classical pathway of complement by a novel C1q-binding peptide derived from the human astrovirus coat protein. MOLECULAR IMMUNOLOGY. 48:305-313.
-
2010Potent inhibition of the classical pathway of complement by a novel C1q-binding peptide derived from the human astrovirus coat protein. MOLECULAR IMMUNOLOGY. 2259-2259.Full Text via DOI: 10.1016/j.molimm.2010.05.185
-
2010Human astrovirus coat protein binds C1q and MBL and inhibits the classical and lectin pathways of complement activation. MOLECULAR IMMUNOLOGY. 47:792-798.Full Text via DOI: 10.1016/j.molimm.2009.10.006 PMID: 19896716
-
2010Potent inhibition of the classical pathway of complement by a novel C1q-binding peptide derived from the human astrovirus coat protein. MOLECULAR IMMUNOLOGY. 48:305-313.Full Text via DOI: 10.1016/j.molimm.2010.07.012 PMID: 20728940
-
2009Human astrovirus coat protein binds C1q and MBL inhibiting the classical and the lectin pathways of complement activation. MOLECULAR IMMUNOLOGY. 2824-2824.Full Text via DOI: 10.1016/j.molimm.2009.05.203
-
2008Human Astrovirus Coat Protein: A Novel C1 Inhibitor. CURRENT TOPICS IN COMPLEMENT II. 632:237-251.Full Text via DOI: 10.1007/978-0-387-78952-1_17 PMID: 19025126
-
2008Human astrovirus coat protein inhibits serum complement activation via C1, the first component of the classical pathway. JOURNAL OF VIROLOGY. 82:817-827.Full Text via DOI: 10.1128/JVI.01847-07 PMID: 17959658
-
2005Complex formation among murine cytomegalovirus US22 proteins encoded by genes M139, M140, and M141. JOURNAL OF VIROLOGY. 79:3525-3535.Full Text via DOI: 10.1128/JVI.79.6.3525-3535.2005 PMID: 15731247
-
2005Identification of structural domains involved in astrovirus capsid biology. VIRAL IMMUNOLOGY. 17-26.
Contact
full name
- Neel K. Krishna